Virosome-formulated synthetic peptides (malaria vaccine)

TERMINATED · PHASE1 · Falciparum Malaria

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.